ロード中...
Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder
To date, there are no biomarkers for major depressive disorder (MDD) treatment response in clinical use. Such biomarkers could allow for individualized treatment selection, reducing time spent on ineffective treatments and the burden of MDD. In search of such a biomarker, multisite pretreatment and...
保存先:
| 出版年: | Neuropsychopharmacology |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6135779/ https://ncbi.nlm.nih.gov/pubmed/29955151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0122-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|